These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 20506326
1. Liposome-bound APO2L/TRAIL is an effective treatment in a rabbit model of rheumatoid arthritis. Martinez-Lostao L, García-Alvarez F, Basáñez G, Alegre-Aguarón E, Desportes P, Larrad L, Naval J, Martínez-Lorenzo MJ, Anel A. Arthritis Rheum; 2010 Aug; 62(8):2272-82. PubMed ID: 20506326 [Abstract] [Full Text] [Related]
2. Rheumatoid synovial fluid T cells are sensitive to APO2L/TRAIL. Martínez-Lorenzo MJ, Anel A, Saez-Gutierrez B, Royo-Cañas M, Bosque A, Alava MA, Piñeiro A, Lasierra P, Asín-Ungría J, Larrad L. Clin Immunol; 2007 Jan; 122(1):28-40. PubMed ID: 16982214 [Abstract] [Full Text] [Related]
3. Liposomes decorated with Apo2L/TRAIL overcome chemoresistance of human hematologic tumor cells. De Miguel D, Basáñez G, Sánchez D, Malo PG, Marzo I, Larrad L, Naval J, Pardo J, Anel A, Martinez-Lostao L. Mol Pharm; 2013 Mar 04; 10(3):893-904. PubMed ID: 23331277 [Abstract] [Full Text] [Related]
4. Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor-related apoptosis-inducing ligand R2 and increased decoy receptor tumor necrosis factor-related apoptosis-inducing ligand R3. Perlman H, Nguyen N, Liu H, Eslick J, Esser S, Walsh K, Moore TL, Pope RM. Arthritis Rheum; 2003 Nov 04; 48(11):3096-101. PubMed ID: 14613271 [Abstract] [Full Text] [Related]
5. Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium. Yao Q, Wang S, Gambotto A, Glorioso JC, Evans CH, Robbins PD, Ghivizzani SC, Oligino TJ. Gene Ther; 2003 Jun 04; 10(12):1055-60. PubMed ID: 12776164 [Abstract] [Full Text] [Related]
9. The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis. Raptopoulou AP, Bertsias G, Makrygiannakis D, Verginis P, Kritikos I, Tzardi M, Klareskog L, Catrina AI, Sidiropoulos P, Boumpas DT. Arthritis Rheum; 2010 Jul 04; 62(7):1870-80. PubMed ID: 20506224 [Abstract] [Full Text] [Related]
10. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. Pollack IF, Erff M, Ashkenazi A. Clin Cancer Res; 2001 May 04; 7(5):1362-9. PubMed ID: 11350907 [Abstract] [Full Text] [Related]
11. Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis. Terzioglu E, Bisgin A, Sanlioglu AD, Ulker M, Yazisiz V, Tuzuner S, Sanlioglu S. Rheumatology (Oxford); 2007 May 04; 46(5):783-9. PubMed ID: 17309888 [Abstract] [Full Text] [Related]
12. Cytotoxic effects of camptothecin and cisplatin combined with tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) in a model of primary culture of non-small cell lung cancer. Frese S, Schüller A, Frese-Schaper M, Gugger M, Schmid RA. Anticancer Res; 2009 Aug 04; 29(8):2905-11. PubMed ID: 19661294 [Abstract] [Full Text] [Related]
13. Ionic complex systems based on hyaluronic acid and PEGylated TNF-related apoptosis-inducing ligand for treatment of rheumatoid arthritis. Kim YJ, Chae SY, Jin CH, Sivasubramanian M, Son S, Choi KY, Jo DG, Kim K, Chan Kwon I, Lee KC, Park JH. Biomaterials; 2010 Dec 04; 31(34):9057-64. PubMed ID: 20813405 [Abstract] [Full Text] [Related]
14. Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis. Jazirehi AR, Ng CP, Gan XH, Schiller G, Bonavida B. Clin Cancer Res; 2001 Dec 04; 7(12):3874-83. PubMed ID: 11751478 [Abstract] [Full Text] [Related]
15. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release. Röhn TA, Wagenknecht B, Roth W, Naumann U, Gulbins E, Krammer PH, Walczak H, Weller M. Oncogene; 2001 Jul 12; 20(31):4128-37. PubMed ID: 11464279 [Abstract] [Full Text] [Related]
16. Immunotherapy with liposome-bound TRAIL overcomes partial protection to soluble TRAIL-induced apoptosis offered by down-regulation of Bim in leukemic cells. De Miguel D, Gallego-Lleyda A, Galan-Malo P, Rodriguez-Vigil C, Marzo I, Anel A, Martinez-Lostao L. Clin Transl Oncol; 2015 Aug 12; 17(8):657-67. PubMed ID: 25967100 [Abstract] [Full Text] [Related]
17. Cooperation between Apo2L/TRAIL and bortezomib in multiple myeloma apoptosis. Balsas P, López-Royuela N, Galán-Malo P, Anel A, Marzo I, Naval J. Biochem Pharmacol; 2009 Mar 01; 77(5):804-12. PubMed ID: 19100720 [Abstract] [Full Text] [Related]
18. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance. Ng CP, Zisman A, Bonavida B. Prostate; 2002 Dec 01; 53(4):286-99. PubMed ID: 12430140 [Abstract] [Full Text] [Related]
19. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report. Catrina AI, Trollmo C, af Klint E, Engstrom M, Lampa J, Hermansson Y, Klareskog L, Ulfgren AK. Arthritis Rheum; 2005 Jan 01; 52(1):61-72. PubMed ID: 15641091 [Abstract] [Full Text] [Related]
20. Soluble neuropilin-2, a nerve repellent receptor, is increased in rheumatoid arthritis synovium and aggravates sympathetic fiber repulsion and arthritis. Fassold A, Falk W, Anders S, Hirsch T, Mirsky VM, Straub RH. Arthritis Rheum; 2009 Oct 01; 60(10):2892-901. PubMed ID: 19790074 [Abstract] [Full Text] [Related] Page: [Next] [New Search]